Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
MYGN
MYRIAD GENETICS INC
NASDAQ · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Last close
$4.31
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market cap
$412.25M
Country
USA
RECENT INSIDER TRADES
2026-09-22
· Wheeler Benjamin Richard
(Chief Financial Officer)
· OTHER
2026-09-17
· Sikri Vishal
(EVP, Commercial)
· OTHER
2026-09-08
· Fox Jennifer Lynne
(Chief Legal Officer)
· OTHER
2026-08-17
· Wheeler Benjamin Richard
(Chief Financial Officer)
· OTHER
2026-06-12
· Donnelly Brian J
(Chief Commerical Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
218
Shares held
117,247,720
Value
$947.76M
Percent of shares outstanding
122.58%
As of quarter end
2026-06-30
RECENT NEWS
Myriad Genetics, SOPHiA partner on prostate cancer biomarker
Myriad Genetics and SOPHiA GENETICS collaborate on prostate genomic instability score
Myriad Genetics appoints Vishal Sikri EVP Commercial
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS